Single cell sequencing of human normal breast myoepithelial cells
The dataset includes 6 FASTQ files with single cell transcriptome sequencing data of normal breast myoepithelial cells from ducts and TDLUs derived from reduction mammoplasties from three patients. Chromium Single Cell 3’ Reagent Kit v2 or v3 (10x Genomics) were used for processing of cells, whereafter sequencing was performed using the Illumina® NextSeq500/550 High Output Kit v2. Cell Ranger was used for generating FASTQ files and files from different lanes were concatenated prior to uploading the data to EGA.
- 6 samples
- DAC: EGAC00001002481
- Technology: NextSeq 550
Data access committee for studying human normal breast cells from reduction mammoplasty tissue
This Data Access Committee (DAC) will evaluate any request provided by a requestor, and grant access to specific datasets to those who fulfill the criteria for data access within EGA. The Data Access Committee (DAC) will aim to respond to all initial requests within 2 weeks. The committee will check that requestors data/EGAD number is consistent with the current data submission (that requestor has contacted the correct DAC). Requestor has to sign up to the terms within the DAA in order to validate that the data are used within terms of consent, and document this to the committee. Requestor has to provide a valid Institutional email address as well as a valid affiliation to an institutional organization. Requestor has to document to be “appropriately qualified/bona fide” for use of the data.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001005933 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.